Fund Infusion

The Rs 5,000-crore funds infusion vastly raises investment capabilities of the company

After balance sheet repair, the difficult part awaits Suzlon

The company has to rapidly grow its business volumes

Will Shanghvi get lucky with Suzlon this time?

In 2015 Shanghvi and associates acquired 100 crore equity shares of Suzlon at Rs 18 per unit. The stock now is at less than half the purchase price

Apollo Hospitals shifts capex focus on delay in digital unit's fund-raising

In the near term it will add to capacity in its existing markets, adding more beds at Chennai and Bengaluru

Tata Power’s green energy business valuation is a reality check for investors

The stake sale values Tata Power’s renewable energy subsidiary at Rs 34,000-38,000 crore, lower than the Street's estimate of Rs 45,000 crore

Vistara gets another Rs 750-crore fund infusion from Tata Sons, Singapore Airlines

In the latest round of fund infusion, Tata Sons would infuse Rs 382.5 crore in Vistara while Singapore Airlines would infuse Rs 367.5 crore.

Vistara gets Rs 465-crore fund infusion from Tata Sons, Singapore Airlines

Vistara plans to expand its operation significantly by 2023, which is the primary reason behind the carrier’s aggressive capital infusion moves. The airline has already started flying to London and Tokyo this year and has filed for permission in the US to fly from September.

Sabyasachi will not stretch Aditya Birla Fashion, scale-up important

Aditya Birla Fashion is well placed to fund its Sabyasachi acquisition. The company has recently raised funds from a stake sale to Flipkart and from a rights issue

Editor's Take | Up to lenders to save Jet Airways

The airline is sitting on a debt mount of Rs 8,000 crore and has continuously defaulted on its loan repayment.

Fund infusion into PSBs not sufficient to support lending growth: Fitch

Fitch estimates that banks will need an additional USD 23 billion (around Rs 1.6 lakh crore) in 2019, after these latest injections, to sufficiently meet minimum capital standards.

Essar Steel stake sale hits a snag, key bidders back out: Srcs

Tata Steel, Liberty House and JSW Steel are believed to have begun talks with Essar's lenders in May to restructure debt, consider fresh fund infusion and increase in the moratorium period.

China pours $67 bn into financial system before holiday

Some analysts have likened the latest fund injections to a loosening of monetary policy or a replacement of funds lost to capital outflows. ANZ Banking Group said the injections have prompted the central bank to hold off lowering the reserve requirement ratio (RRR) for banks

SpiceJet CCI nod seen this week; cap infusion ex post facto

The plans to recapitalise and revive SpiceJet may have been finalized as far as prospective new promoters are concerned but crucial approvals are yet to come in. Sindhu Bhattacharya and Areeb Sherwani report that white knight Ajay Singh hopes antitrust regulator Competition Commission of India will wave the green flag before the week is out.

Govt prepares 4-year blueprint for fund infusion in PSBs

As per the blueprint, infusion will vary from Rs 44,000 crore to Rs 58,000 crore over the stipulated time span.

PNB to raise Rs 1250 cr by issuing preference share to govt

State-owned Punjab National Bank (PNB) today approved a fund infusion of Rs 1,250 crore through preferential issue of shares to the government.

Need Rs 12K-17K crore in 2 yrs; see signs of revival: SBI

Diwakar Gupta, MD & CFO of State Bank of India informed that they are undertaking road shows to focus on under valuation of public sector banks and to attract foreign institutional investors.